Key facts
- Notable investors include Loyal Valley Capital, Jiaxing Deshi Private Equity Fund Management, Kaitai Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Baidiboyuan Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Baidiboyuan Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Baidiboyuan Biotechnology
Manufacturer of biopharmaceutical products intended to advance medical innovation and biotechnology applications. The company offers nucleic acid drug development expertise, biomedical technology capabilities, and strong intellectual property, enabling pharmaceutical enterprises and research institutions to accelerate drug discovery and improve therapeutic advancements.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
Baidiboyuan Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Baidiboyuan Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Baidiboyuan Biotechnology in its N-PORT filings yet. We sweep new filings monthly.